LCN2 and neoplasm: In two pancreatic ductal adenocarcinoma cell lines (BxPC3 and HPAF-II), the downregulation of LCN2 significantly reduces attachment, invasion and tumour growth in vivo, but not proliferation or motility (Leung et al., 2012).